Therefore it can be speculated whether FGFR-signalling contributes to adrenocortical tumour growth by the upstream activation of WNT/beta catenin independently from activating mutations of CTNNB1. The gene discussed is CTNNB1; the disease is adrenal cortex neoplasm.